Oramed Pharmaceuticals Inc. ( ORMP) - Stock Earnings
ORMP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
ORMP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 10.0 million USD | — USD |
| 2026Q1 | 38.3 million USD | — USD |
| 2026Q2 | 78.2 million USD | — USD |
| 2026Q4 Est. | — | — |
ORMP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.5 million USD | 1.3 million USD |
| 2024 | -19.1 million USD | — USD |
| 2025 | 64.1 million USD | 2.0 million USD |
| 2026 Est. | — | — |
ORMP
Price: $4.07
Dividend Yield: 5.57%
Earnings Per Share: 4.13 USD
P/E Ratio: 1.16
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.6 million
Ebitda: -2.5 millionMarket Capitalization: 183.8 million
Years Paying Dividends: 1